Skip to content
Certified ManufacturersFor manufacturers

Aloe Vera of America, Inc.

Dallas, TX, United States

Due-diligence report

Find an accredited testing lab and confirm its scope covers your product and methods.

Aloe Vera of America, Inc. is a dietary supplement manufacturer in Dallas, TX, United States, certified to NSF/ANSI 455-2, NSF/ANSI 455-3 and NSF/ANSI 455-4 GMP, with 1 manufacturing facility on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. Listed dosage forms: gummies, liquids, powders, softgels and tablets.

Facilities listed
1
Last checked

Dosage forms

As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.

Certified facilities

Manufacturing (1)

  • 13745 Jupiter Road, Dallas, TX 75238, United States

    • Coating
    • Dry Formulation
    • Kits
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Quality Unit Operations
    • Tablet Compression
    • Warehousing
    • Liquid Formulation

How Aloe Vera of America, Inc. compares

Among the 769 manufacturers we list, as of our last check.

FDA recall records

No food or dietary supplement recall found under the name Aloe Vera of America, Inc. in FDA’s enforcement reports, as of .

We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check

FDA inspections

FDA lists 5 food or dietary supplement inspections at facilities matching Aloe Vera of America, Inc., from 2010 to 2025, as of . 2 found no objectionable conditions and 3 found conditions the firm was left to correct.

  • No action indicated · No objectionable conditions found

    Inspected

    Dallas, Texas

    FEI 1629180

  • No action indicated · No objectionable conditions found

    Inspected

    Dallas, Texas

    FEI 1629180

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Dallas, Texas

    6 citations posted:

    • Physical plant - screening against pests (21 CFR 111.20(h))
    • Instruments - calibration (21 CFR 111.27(b))
    • Equipment - maintain, clean, sanitize (21 CFR 111.27(d))
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    See all 6 citations
    • Physical plant - screening against pests (21 CFR 111.20(h))

      Your physical plant did not use adequate screening or other protection against pests.

    • Instruments - calibration (21 CFR 111.27(b))

      You did not calibrate instruments or controls used in manufacturing or testing a component or dietary supplement to ensure the accuracy and precision of the instruments or controls.

    • Equipment - maintain, clean, sanitize (21 CFR 111.27(d))

      You did not clean equipment and utensils used to manufacture, package, label, or hold components or dietary supplements.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the identity, purity, strength and composition of the finished dietary supplement.

    • Examination, testing; appropriate (21 CFR 111.320(a))

      You did not verify that the laboratory examination and testing methodologies are appropriate for their intended use.

    • Written procedures - product complaint; review, investigate (21 CFR 111.570(b)(1))

      You did not make and keep written procedures to fulfill the requirements that apply to the review and investigation of a product complaint.

    FEI 1629180

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Dallas, Texas

    15 citations posted:

    • Precluding contaminants (21 CFR 110.40(a))
    • Personnel - records - training (21 CFR 111.14(b)(2))
    • Physical plant - screening against pests (21 CFR 111.20(h))
    • Specifications - contamination limits (21 CFR 111.70(b)(3))
    See all 15 citations
    • Precluding contaminants (21 CFR 110.40(a))

      The use of equipment and utensils fails to preclude the adulteration of food with contaminants.

    • Personnel - records - training (21 CFR 111.14(b)(2))

      You did not make and keep documentation of training.

    • Physical plant - screening against pests (21 CFR 111.20(h))

      Your physical plant did not use adequate screening or other protection against pests.

    • Specifications - contamination limits (21 CFR 111.70(b)(3))

      You did not establish limits for contamination that may adulterate or may lead to adulteration of the finished dietary supplement.

    • Quality control - processes, specifications, written procedures (21 CFR 111.105(a))

      Your quality control personnel did not approve or reject specifications that may affect the identity, purity, strength, or composition of a dietary supplement.

    • Quality control - adulteration; material review, disposition (21 CFR 111.113(a)(3))

      Your quality control personnel did not conduct a material review and make a disposition decision for an unanticipated occurrence during the manufacturing operations that adulterated or may lead to adulteration of the dietary supplement.

    • Quality control operations - equipment records (21 CFR 111.117(c))

      Your quality control operations did not include periodically reviewing all records for calibrations, inspections, or checks of mechanical equipment.

    • Quality control - finished batch, distribution (21 CFR 111.123(a)(8))

      Your quality control operations did not include approving and releasing, or rejecting, each finished batch for distribution.

    • Master manufacturing record theoretical and expected yield (21 CFR 111.210(f))

      Your master manufacturing record did not include a statement of the theoretical yield for each point, step, or stage of the manufacturing process to ensure quality control

    • Components, verify weight, measure (21 CFR 111.210(h)(3)(i))

      The written instructions in your master manufacturing record did not include instructions to verify the weight or measure and addition of components.

    • Batch record - yield (21 CFR 111.260(f))

      Your batch production records did not include a statement of the percentage of theoretical yield at appropriate phases of processing.

    • Sampling plans; finished batches (21 CFR 111.315(b)(3))

      You did not establish sampling plans for obtaining representative samples of finished batches of dietary supplements.

    • Standard reference materials; criteria for selecting (21 CFR 111.315(d))

      You did not establish and follow laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations.

    • Written procedures, laboratory operations (21 CFR 111.325(a))

      You did not make and keep written procedures for laboratory operations.

    • Lack of written stability program (21 CFR 211.166(a))

      There is no written testing program designed to assess the stability characteristics of drug products.

    FEI 1629180

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Dallas, Texas

    20 citations posted:

    • Physical plant - repair (21 CFR 111.15(b)(2))
    • Cleaning compounds (21 CFR 111.15(c)(1))
    • Hand-washing facilities (21 CFR 111.15(i))
    • Instruments - calibration (21 CFR 111.27(b))
    See all 20 citations
    • Physical plant - repair (21 CFR 111.15(b)(2))

      You did not maintain your physical plant in repair sufficient to prevent components, dietary supplements, or contact surfaces from becoming contaminated.

    • Cleaning compounds (21 CFR 111.15(c)(1))

      You did not use cleaning compounds that are safe and adequate under the conditions of use.

    • Hand-washing facilities (21 CFR 111.15(i))

      Your hand-washing facilities are not convenient.

    • Instruments - calibration (21 CFR 111.27(b))

      You did not calibrate instruments or controls used in manufacturing or testing a component or dietary supplement before the first use to ensure the accuracy and precision of the instruments or controls.

    • Document-equipment date of use, maintain, clean, sanitize (21 CFR 111.35(b)(2))

      You did not make and keep documentation of maintenance of the equipment.

    • Production, in- process control system - design, quality (21 CFR 111.60(a))

      Your production and in-process control system is not designed to ensure that the dietary supplement is manufactured, packaged, labeled, and held in a manner that will ensure the quality of the dietary supplement.

    • Specifications - contamination limits (21 CFR 111.70(b)(3))

      You did not establish limits for contamination that may adulterate or may lead to adulteration of the finished dietary supplement.

    • In-process identity, purity, strength, composition (21 CFR 111.70(c)(1))

      You did not establish in-process specifications for a point, step, or stage in the master manufacturing record where control is necessary to help ensure that specifications are met for strength.

    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))

      You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.

    • Quality control - finished batch, distribution (21 CFR 111.123(a)(8))

      Your quality control operations did not include approving and releasing, or rejecting, each finished batch for distribution.

    • Material review, disposition, follow-up; identification (21 CFR 111.140(b)(3)(iv))

      Your documentation of your material review and disposition decision and followup did not include identification of the action taken to correct, and prevent a recurrence of, the deviation or the unanticipated occurrence.

    • Written procedures - packaging, labeling received (21 CFR 111.180(b)(1))

      You did not make and keep written procedures for fulfilling the requirements that apply to packaging and labeling received.

    • Master manufacturing record - each batch (21 CFR 111.205(a))

      You did not follow a written master manufacturing record for each batch size of a dietary supplement that you manufactured.

    • Master manufacturing record - intentional overage (21 CFR 111.210(e))

      Your master manufacturing record did not include a statement of intentional overage amount of a dietary ingredient.

    • Batch record - results; monitoring (21 CFR 111.260(g))

      Your batch production records did not include the actual results obtained during a monitoring operation.

    • Examination, testing; appropriate (21 CFR 111.320(a))

      You did not verify that the laboratory examination and testing methodologies are appropriate for their intended use.

    • Laboratory methodology followed (21 CFR 111.325(b)(2))

      You did not make and keep documentation that established laboratory methodology was followed.

    • Packaging - issuance, use (21 CFR 111.410(b))

      You did not control the issuance and use of packaging.

    • Sample size - test intervals (21 CFR 211.166(a)(1))

      The written stability program for drug products does not include test intervals based on statistical criteria for each attribute examined to assure valid estimates of stability.

    • Review of representative number of batches (21 CFR 211.180(e)(1))

      Written procedures are not established and followed for evaluations conducted at least annually to review records associated with a representative number of batches, whether approved or rejected.

    FEI 1629180

We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check

What we checked, and what we didn’t

Confirmed from NSF’s public listing

Last checked

  • NSF/ANSI 455-2 GMP certification
  • NSF/ANSI 455-3 GMP certification
  • NSF/ANSI 455-4 GMP certification
  • 1 facility address
  • Dosage forms in the certified scope
  • Operations listed for each facility

Not verified by us

  • Minimum order quantity (MOQ): the smallest order they accept
  • Lead times and current capacity
  • Prices
  • Other certifications, like organic, kosher, halal or NSF Certified for Sport
  • Whether they’re taking new clients
  • Conditions inside the facility. We don’t visit or audit facilities.

Ask about these in your quote request. How we verify

Other gummy manufacturers in the United States

  1. NSF lists 4 gummy facilities, including one in Tempe, AZ

    Tempe, AZ, United States21stcenturyvitamins.com

    • Capsules
    • Gummies
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    NSF/ANSI 455-2checked Nov 19, 2026
  2. NSF lists a gummy facility in Garden Grove, CA

    Garden Grove, CA, United Statespackaging.com

    • Capsules
    • Gummies
    • Powders
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Nov 19, 2026
  3. NSF lists 2 gummy facilities, including one in St. Augustine, FL

    St. Augustine, FL, United Statesactivegummy.com

    • Gummies
    Operations:
    • Molding
    • Coating
    NSF/ANSI 455-2checked Nov 19, 2026
  4. NSF lists a gummy facility in Merrilville, IN

    Merrilville, IN, United Statesalbanesecandy.com

    • Gummies
    Operations:
    • Molding
    • Liquid formulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  5. NSF lists a gummy facility in Miami, FL

    Miami, FL, United Statesalfavitamins.com

    • Capsules
    • Gummies
    • Liquids
    • Softgels
    • Tablets
    Operations:
    • Pasteurization
    • Coating
    • Liquid formulation
    • Tablet compression
    • +1 more
    NSF/ANSI 455-2checked Nov 19, 2026
  6. NSF lists a gummy facility in Ontario, CA

    Ontario, CA, United Statesalphaplustech.us

    • Capsules
    • Gummies
    • Liquids
    • Oils
    • Powders
    • Softgels
    • +1 more
    Operations:
    • Liquid formulation
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026